Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 24314812)

1.

Walker 256/B malignant breast cancer cells disrupt osteoclast cytomorphometry and activity in rats: modulation by α-tocopherol acetate.

Badraoui R, Ben-Nasr H, Amamou S, El-May MV, Rebai T.

Pathol Res Pract. 2014 Mar;210(3):135-41. doi: 10.1016/j.prp.2013.11.002. Epub 2013 Nov 15.

PMID:
24314812
2.

Effect of alpha tocopherol acetate in Walker 256/B cells-induced oxidative damage in a rat model of breast cancer skeletal metastases.

Badraoui R, Blouin S, Moreau MF, Gallois Y, Rebai T, Sahnoun Z, Baslé M, Chappard D.

Chem Biol Interact. 2009 Dec 10;182(2-3):98-105. doi: 10.1016/j.cbi.2009.09.010. Epub 2009 Sep 23.

PMID:
19781538
3.

Walker 256/B malignant breast cancer cells improve femur angioarchitecture and disrupt hematological parameters in a rat model of tumor osteolysis.

Badraoui R, Boubakri M, Bedbabiss M, Ben-Nasr H, Rebai T.

Tumour Biol. 2014 Apr;35(4):3663-70. doi: 10.1007/s13277-013-1485-5. Epub 2013 Dec 8.

PMID:
24318993
4.
6.

Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo.

Idris AI, Libouban H, Nyangoga H, Landao-Bassonga E, Chappard D, Ralston SH.

Mol Cancer Ther. 2009 Aug;8(8):2339-47. doi: 10.1158/1535-7163.MCT-09-0133. Epub 2009 Aug 11.

7.

Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.

Rissanen JP, Suominen MI, Peng Z, Halleen JM.

Calcif Tissue Int. 2008 Feb;82(2):108-15. Epub 2007 Dec 15.

PMID:
18084692
8.
9.

A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.

Ohno H, Kubo K, Murooka H, Kobayashi Y, Nishitoba T, Shibuya M, Yoneda T, Isoe T.

Mol Cancer Ther. 2006 Nov;5(11):2634-43.

10.

Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.

Meng Y, Zhang H, Li Y, Li Q, Zuo L.

Bone. 2014 Jan;58:168-76. doi: 10.1016/j.bone.2013.10.010. Epub 2013 Oct 18.

PMID:
24145307
11.

The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo.

Vandyke K, Dewar AL, Diamond P, Fitter S, Schultz CG, Sims NA, Zannettino AC.

J Bone Miner Res. 2010 Aug;25(8):1759-70. doi: 10.1002/jbmr.85.

PMID:
20225261
12.

Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.

Strube A, Hoffmann J, Stepina E, Hauff P, Klar U, Käkönen SM.

Clin Cancer Res. 2009 Jun 1;15(11):3751-9. doi: 10.1158/1078-0432.CCR-08-3123. Epub 2009 May 26.

13.

Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.

Nakata A, Tsujimura T, Sugihara A, Okamura H, Iwasaki T, Shinkai K, Iwata N, Kakishita E, Akedo H, Terada N.

Anticancer Res. 1999 Sep-Oct;19(5B):4131-8.

PMID:
10628364
14.
15.

Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.

Xu D, Yang W, Zhou C, Liu Y, Xu B.

Planta Med. 2010 Nov;76(16):1809-13. doi: 10.1055/s-0030-1250040. Epub 2010 Jun 24.

PMID:
20577944
16.

Short-term treatment of recombinant murine interleukin-4 rapidly inhibits bone formation in normal and ovariectomized mice.

Okada Y, Morimoto I, Ura K, Nakano Y, Tanaka Y, Nishida S, Nakamura T, Eto S.

Bone. 1998 Apr;22(4):361-5.

PMID:
9556136
17.

Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number.

Holloway WR, Collier FM, Herbst RE, Hodge JM, Nicholson GC.

Bone. 1996 Aug;19(2):137-42.

PMID:
8853857
18.

Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.

Das S, Samant RS, Shevde LA.

J Biol Chem. 2011 Mar 18;286(11):9612-22. doi: 10.1074/jbc.M110.174920. Epub 2010 Dec 18.

19.

Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.

Sasaki A, Alcalde RE, Nishiyama A, Lim DD, Mese H, Akedo H, Matsumura T.

Cancer Res. 1998 Feb 1;58(3):462-7.

20.

Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis.

Clohisy DR, Palkert D, Ramnaraine ML, Pekurovsky I, Oursler MJ.

J Orthop Res. 1996 May;14(3):396-402.

PMID:
8676252
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk